Tandem Mass Spectrometry Molecular Networking as a Powerful and Efficient Tool for Drug Metabolism Studies

被引:28
|
作者
Yu, Jun Sang [1 ]
Nothias, Louis-Felix [2 ]
Wang, Mingxun [2 ]
Kim, Dong Hyun [3 ]
Dorrestein, Pieter C. [2 ]
Kang, Kyo Bin [4 ]
Yoo, Hye Hyun [1 ]
机构
[1] Hanyang Univ, Inst Pharmaceut Sci & Technol, Ansan 15588, South Korea
[2] Univ Calif San Diego, Collaborat Mass Spectrometry Innovat Ctr, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA
[3] Inje Univ, Dept Pharmacol, Coll Med, Busan 47392, South Korea
[4] Sookmyung Womens Univ, Coll Pharm, Res Inst Pharmaceut Sci, Seoul 04310, South Korea
基金
新加坡国家研究基金会; 美国国家卫生研究院;
关键词
PRODUCTS; DEFECT; ANNOTATION; SILDENAFIL; IDENTIFICATION; DISCOVERY; MS/MS; MS;
D O I
10.1021/acs.analchem.1c04925
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Molecular networking (MN) has become a popular data analysis method for untargeted mass spectrometry (MS)/MS-based metabolomics. Recently, MN has been suggested as a powerful tool for drug metabolite identification, but its effectiveness for drug metabolism studies has not yet been benchmarked against existing strategies. In this study, we compared the performance of MN, mass defect filtering, Agilent MassHunter Metabolite ID, and Agilent Mass Profiler Professional workflows to annotate metabolites of sildenafil generated in an in vitro liver microsome-based metabolism study. Totally, 28 previously known metabolites with 15 additional unknown isomers and 25 unknown metabolites were found in this study. The comparison demonstrated that MN exhibited performances comparable or superior to those of the existing tools in terms of the number of detected metabolites (27 known metabolites and 22 unknown metabolites), ratio of false positives, and the amount of time and effort required for human labor-based postprocessing, which provided evidence of the efficiency of MN as a drug metabolite identification tool.
引用
收藏
页码:1456 / 1464
页数:9
相关论文
共 50 条
  • [31] Mass spectrometry imaging as a powerful tool for detailed molecular investigation of brain pathologies: molecular microscope for peroxisomal disorders
    Skraskova, K.
    Khmelinskii, A.
    Abdelmoula, W. M.
    De Munter, S.
    Baes, M.
    Heeren, R. M. A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S332 - S332
  • [32] Mass spectrometry imaging in drug distribution and drug metabolism studies - Principles, applications and perspectives
    Granborg, Jonatan Riber
    Handler, Anne Mette
    Janfelt, Christian
    TRAC-TRENDS IN ANALYTICAL CHEMISTRY, 2022, 146
  • [33] Molecular modeling: A powerful tool for drug design and molecular docking
    Rama Rao Nadendla
    Resonance, 2004, 9 (5) : 51 - 60
  • [34] Membrane Inlet Mass Spectrometry: A Powerful Tool for Algal Research
    Burlacot, Adrien
    Burlacot, Francois
    Li-Beisson, Yonghua
    Peltier, Gilles
    FRONTIERS IN PLANT SCIENCE, 2020, 11
  • [35] Fourier transform mass spectrometry:: A powerful tool for toxin analysis
    Quinton, Loic
    Le Caer, Jean-Pierre
    Vinh, Joelle
    Gilles, Nicolas
    Chamot-Rooke, Julia
    TOXICON, 2006, 47 (06) : 715 - 726
  • [36] Determination of N-desethylamodiaquine by hydrophilic interaction liquid chromatography with tandem mass spectrometry:: Application to in vitro drug metabolism studies
    Dravid, Prajakta V.
    Frye, Reginald F.
    JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2008, 863 (01): : 129 - 134
  • [37] Tandem mass spectrometry as screening for inborn errors of metabolism
    Campos H, Derbis
    REVISTA MEDICA DE CHILE, 2011, 139 (10) : 1356 - 1364
  • [38] Diagnosis of inborn errors of metabolism by tandem mass spectrometry
    Ozand, PT
    ANNALS OF SAUDI MEDICINE, 1998, 18 (03) : 234 - 238
  • [39] TANDEM MASS-SPECTROMETRY STUDIES OF METALLOFULLERENES
    CALLAHAN, JH
    NELSON, H
    MCELVANY, SW
    ROSS, MM
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1993, 205 : 217 - PHYS
  • [40] Molecular hybridization: a powerful tool for multitarget drug discovery
    Pinheiro, Pedro de Sena Murteira
    Franco, Lucas Silva
    Montagnoli, Tadeu Lima
    Fraga, Carlos Alberto Manssour
    EXPERT OPINION ON DRUG DISCOVERY, 2024, 19 (04) : 451 - 470